Skeletal muscle wastage in Crohn's disease: A pathway shared with heart failure?

International Journal of Cardiology

Volumn 127, Issue 2, 2008, Pages 219-227

  Cuoco, Lucio ^a   Vescovo, Giorgio ^a   Castaman, Roberto ^a   Ravara, Barbara ^b   Cammarota, Giovanni ^a   Angelini, Annalisa ^c   Salvagnini, Mario ^a   Dalla Libera, Luciano ^b  

^a SAN BORTOLO HOSPITAL   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Intestinal permeability in Chron's disease; LPS; Skeletal muscle wastage; Sphingosine; TNF

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; MYOSIN HEAVY CHAIN; SPHINGOSINE; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; FEMALE; GASTROCNEMIUS MUSCLE; HEART FAILURE; HUMAN; HUMAN TISSUE; INFLAMMATION; INTESTINE MUCOSA PERMEABILITY; LEAN BODY WEIGHT; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE CELL; MYOPATHY; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; SKELETAL MUSCLE; STATISTICAL SIGNIFICANCE; TISSUE SECTION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; APOPTOSIS; BIOPSY; BODY COMPOSITION; CASE-CONTROL STUDIES; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HUMANS; IN SITU NICK-END LABELING; INTESTINAL ABSORPTION; LINEAR MODELS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOSIN HEAVY CHAINS; NUTRITIONAL STATUS; SPHINGOSINE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 44649103188     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.06.006     Document Type: Article

References (57)

1. Heaton K.W. Dietary factors in the aetiology of IBD. In: Allan R.N., Keighley M.R.B., Alexander-Williams J., et al. (Eds). Inflammatory bowel diseases. ed. 2 (1990), Edinburgh, Churchill Livingstone 165-169
2. Stokes M.A. Crohn's disease and nutrition. Br J Surg 79 (1992) 391-394
3. Shoda R., Matsueda K., Yamato S., et al. Epidemiologic analysis of Crohn's disease in Japan: increased dietary intake of n-6 polyunsatured fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 63 (1996) 741-745
4. Mayberry J.F. Recent epidemiology of ulcerative colitis and Crohn's disease. Int J Colorectal Dis 4 (1999) 59-66
5. Vescovo G., and Dalla Libera L. Skeletal muscle apoptosis in experimental heart failure. The only link between inflammation and skeletal muscle wastage?. Curr Opin Clin Nutr Metab Care 9 (2006) 416-422
6. Chamberlain J.S. Cachexia in cancer zeroing in on myosin. N Engl J Med 351-20 (2004) 2124-2125
7. Bernstein C.N., Blanchard J.F., Leslie W., et al. The incidence of fracture among patients with inflammatory bowel disease. Ann Intern Med 133 (2000) 795-799
8. Jahnsen J., Falch J.A., Aadland E., et al. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population-based study. Gut 40 (1997) 313-319
9. Klaus J., Ambrecht G., Steinkamp M., et al. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut 51 (2002) 654-658
10. Lamb E.J., Wong T., and Smith D.J. Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 16 (2002) 1895-1902
11. De Jong D.J., Corstens F.H., Mannaerts L., et al. Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease?. Am J Gastroenterol 97 (2002) 2011-2015
12. Elsborg L., and Larsen L. Folate deficiency in chronic inflammatory bowel diseases. Scand J Gastroenterol 14 (1979) 1019-1024
13. Dieleman L.A., and Heize W.D. Nutritional issues in inflammatory bowel diseases. Gastroenterol Clin North Am 27 (1998) 1-11
14. Fernandez-Banares F., Mingorance M.D., Esteve M., et al. Serum zinc, copper and selenium levels in IBD: effect of total enteral nutrition on trace element status. Am J Gastroenterol 85 (1990) 1584-1589
15. Goh J., and O'Morain C.A. Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther 17 (2003) 307-320
16. Han P.D., Burke A., Baldassano R.N., et al. Nutrition and inflammatory bowel disease. Gastroenterol Clin North Am 28 (1999) 423-443
17. Cabrè E., and Gassull M.A. Nutritional and metabolic issues in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 6 (2003) 569-576
18. Capristo E., Mingrone G., Addolorato G., et al. Metabolic features in inflammatory bowel disease in a remission phase of the disease activity. J Intern Med 243 (1998) 339-347
19. Al-Jaouni R., Hèbuterne X., Pouget I., et al. Energy metabolism and substrate oxidation in patients with Crohn's disease. Nutrition 16 (2000) 173-178
20. Al-Jaouni R., Schneider S.M., Piche T., et al. Effect of steroid on energy metabolism and substrate oxidation in women with Crohn's disease. Am J Gastroenterol 97 (2002) 2843-2849
21. Geerling B.J., Badart-Smook A., Stockbrugger R.W., et al. Comprehensive nutritional status in patients with longstanding Crohn's disease in remission. Am J Clin Nutr 67 (1998) 919-926
22. Lopes J., Russell D.M.C.R., Whitwell J., et al. Skeletal muscle function in malnutrition. Am J Clin Nutr 36 (1982) 602-610
23. Vescovo G., Serafini F., Facchin L., et al. Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. Heart 76 (1996) 337-343
24. Vescovo G., Dalla Libera L., Serafini F., et al. Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition. Circulation 98 (1998) 1742-1749
25. Wilson J.R., Mancini D.M., and Dunkman W.B. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation 87 (1993) 470-475
26. Puigserver P., and Spiegelman B.M. Peroxisome proliferators-activated receptor-g coactivator 1a (PGC-1a): transcriptional coactivator and metabolic regulator. Endocr Rev 24 (2002) 78-90
27. Lin J., Wu H., Tarr P.T., et al. Transcriptional co-activator PGC-1a drives the formation of slow twitch muscle fibres. Nature 418 (2002) 797-801
28. Vescovo G., Ravara B., Gobbo V., et al. Skeletal muscle fibres synthesis in heart failure: role of PGC-1α calcineurin and GH. Int J Cardiol 104 (2005) 298-306
29. Skurk C., Izumiya Y., Maatz H., et al. The FOXO3 a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J Biol Chem 280 (2005) 20814-20823
30. Sandri M., Sandri C., Gilbert A., et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117 (2004) 399-412
31. Anker S.D., Swan J.W., Volterrani M., et al. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J 18 (1997) 259-269
32. Vescovo G., Zennaro R., and Sandri M. Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure. J Mol Cell Cardiol 30 (1998) 2449-2459
33. Vescovo G., Volterrani M., Zennaro R., et al. Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart 84 (2000) 431-437
34. Dalla Libera L., Zennaro R., Sandri M., et al. Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure. Am J Physiol 277 (1999) C982-C986
35. Dalla Libera L., Sabbadini R., Renken C., et al. Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-alpha and sphingosine. J Mol Cell Cardiol 33 (2001) 1871-1878
36. Niebauer J., Volk H.D., Kemp M., et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353 (1999) 1838-1842
37. Rauchhaus M., Koloczek V., Volk H., et al. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol 76 (2000) 125-133
38. Krown K.A., Page W., Nguyen C., et al. Tumor necrosis factor a-induced apoptosis in cardiac myocytes. Involvement of the sphingolipids signaling cascade in cardiac cell death. J Clin Invest 98 (1996) 2854-2865
39. Fowler E.V., Eri R., Hume G., et al. TNFalpha and IL10 SNPs act together to predict disease behaviour in Crohn's disease. J Med Genet 42 (2005) 523-528
40. Capristo E., Addolorato G., Mingrone G., et al. Effect of disease localization on the anthropometric and metabolic features of Crohn's disease. Am J Gastroenterol 93 (1998) 2411-2419
41. Baldassano R.N., and Piccoli D.A. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am 28 (1999) 445-458
42. Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. N Engl J Med 235 (1991) 525-532
43. Dalla Libera L., Ravara B., Angelini A., et al. Beneficial effects on skeletal muscle of the Angiotensin II Type 1 receptor blocker Irbesartan in experimental heart failure. Circulation 103 (2001) 2195-2200
44. Vescovo G., Ravara B., Gobbo V., et al. L-Carnitine: a potenziale treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure. Am J Physiol Cell Physiol 283 (2002) C802-C810
45. Sandri M., and Carraro U. Apoptosis of skeletal muscles during development and disease. Int J Biochem Cell Biol 31 (1999) 1373-1390
46. Jeejeebhoy K.N. The many faces of malnutrition in Crohn's disease. Am J Clin Nutr 67 (1998) 819-820
47. Jahnsen J., Falch J.A., Mowinckel P., et al. Body composition in patients with inflammatory bowel disease: a population based-study. Am J Gastroenterol 98 (2003) 1556-1562
48. Geerling B.J., Badart-Smook A., Stockbrugger R.W., et al. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr 54 (2000) 514-521
49. Royall D., Greenberg G.R., Allard J.P., et al. Total enteral nutrition support improves body composition of patients with active Crohn's disease. J Parenter Enter Nutr 19 (1995) 95-99
50. Tjellesen L., Nielsen P.K., and Staun M. Body composition by dual-energy X-ray absorptiometry in patients with Crohn's disease. Scand J Gastroenterol 33 (1998) 956-960
51. Dalla Libera L., Ravara B., Volterrani M., et al. Beneficial effects of Gh/IGF-1 on skeletal muscle atrophy and function in experimental heart failure. Am J Physiol Cell Physiol 286 (2004) C138-C144
52. Mann D.L. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91 (2002) 988-998
53. Jensen M.B., Houborg K.B., Vestergaard P., et al. Improved physical performance and increased lean tissue and fat mass in patients with ulcerative colitis four to six years after ileoanal anastomosis with a J-pouch. Dis Colon Rectum 45 (2002) 1601-1607
54. Gronbaek H., Thogersen T., Frystyk J., et al. Low free and total insulin like growth factor I (IGF-I) and IGF binding protein 3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment. Am J Gastroenterol 97 (2002) 673-678
55. Corkins M.R., Gohil A.D., and Fitzgeral J.F. The insulin-like growth factor axis in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 36 (2003) 228-234
56. Mauras N., Gorge D., Evans J., et al. Growth hormone has anabolic effects in glucocorticosteroid dependent children with inflammatory bowel disease: a pilot study. Metabolism 51 (2002) 127-135
57. Langhans W. Anorexia of infection: current prospect. Nutrition 16 (2000) 996-1005